2015 Q2 Form 10-Q Financial Statement

#000114420415031615 Filed on May 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $261.0K $217.0K $85.00K
YoY Change -18.44% 155.29% -5.56%
Cost Of Revenue $96.00K $90.00K $49.00K
YoY Change -42.51% 83.67% -22.22%
Gross Profit $165.0K $127.0K $36.00K
YoY Change 7.84% 252.78% 56.52%
Gross Profit Margin 63.22% 58.53% 42.35%
Selling, General & Admin $981.0K $1.070M $1.264M
YoY Change -36.13% -15.35% 8.87%
% of Gross Profit 594.55% 842.52% 3511.11%
Research & Development $0.00 $60.00K
YoY Change -100.0%
% of Gross Profit 0.0% 166.67%
Depreciation & Amortization $260.0K $10.00K $11.00K
YoY Change 36.84% -9.09% 175.0%
% of Gross Profit 157.58% 7.87% 30.56%
Operating Expenses $1.020M $1.070M $1.341M
YoY Change -39.29% -20.21% 15.5%
Operating Profit -$855.0K -$943.0K -$1.305M
YoY Change -44.01% -27.74% 14.67%
Interest Expense $10.00K -$40.00K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $3.000K
YoY Change -99.86%
Pretax Income -$850.0K -$1.381M -$1.302M
YoY Change -44.26% 6.07% -229.17%
Income Tax $0.00 $0.00 -$10.00K
% Of Pretax Income
Net Earnings -$851.0K -$1.294M -$1.122M
YoY Change -38.82% 15.33% -205.75%
Net Earnings / Revenue -326.05% -596.31% -1320.0%
Basic Earnings Per Share -$0.13
Diluted Earnings Per Share -$52.14K -$114.6K -$0.13
COMMON SHARES
Basic Shares Outstanding 14.04M shares 8.796M shares
Diluted Shares Outstanding 8.796M shares

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.100M $1.400M $3.200M
YoY Change -54.17% -56.25% 18.52%
Cash & Equivalents $1.100M $1.400M $1.455M
Short-Term Investments
Other Short-Term Assets $100.0K $200.0K $200.0K
YoY Change -50.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $51.00K
Other Receivables $300.0K $300.0K $0.00
Total Short-Term Assets $1.500M $1.800M $3.425M
YoY Change -44.44% -47.45% 18.1%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $34.00K
YoY Change -100.0%
Goodwill $6.444M $6.444M
YoY Change 0.0%
Intangibles $2.306M
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $4.000K
YoY Change -100.0% -100.0% -99.8%
Total Long-Term Assets $8.600M $8.800M $8.926M
YoY Change -9.47% -1.41% 134.89%
TOTAL ASSETS
Total Short-Term Assets $1.500M $1.800M $3.425M
Total Long-Term Assets $8.600M $8.800M $8.926M
Total Assets $10.10M $10.60M $12.35M
YoY Change -17.21% -14.18% 84.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $400.0K $228.0K
YoY Change -25.0% 75.44% 14.0%
Accrued Expenses $200.0K $300.0K $134.0K
YoY Change 100.0% 123.88% -33.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.200M $1.492M $632.0K
YoY Change -7.69% 136.08% 58.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.200M $1.492M $632.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.220M $1.492M $632.0K
YoY Change -57.93% 136.08% -89.81%
SHAREHOLDERS EQUITY
Retained Earnings -$300.5M -$295.0M
YoY Change 1.87%
Common Stock $309.5M $305.0M
YoY Change 1.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.600M $8.727M $9.782M
YoY Change
Total Liabilities & Shareholders Equity $10.10M $10.57M $12.35M
YoY Change -17.21% -14.39% 84.34%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$851.0K -$1.294M -$1.122M
YoY Change -38.82% 15.33% -205.75%
Depreciation, Depletion And Amortization $260.0K $10.00K $11.00K
YoY Change 36.84% -9.09% 175.0%
Cash From Operating Activities -$850.0K -$1.000M -$1.420M
YoY Change -18.27% -29.58% 84.42%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $41.00K
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$150.0K $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$150.0K -$40.00K
YoY Change -100.0% 275.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.695M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 570.0K 1.070M 1.470M
YoY Change -149.57% -27.21%
NET CHANGE
Cash From Operating Activities -850.0K -1.000M -1.420M
Cash From Investing Activities 0.000 -150.0K -40.00K
Cash From Financing Activities 570.0K 1.070M 1.470M
Net Change In Cash -280.0K -80.00K 10.00K
YoY Change -87.44% -900.0% -101.3%
FREE CASH FLOW
Cash From Operating Activities -$850.0K -$1.000M -$1.420M
Capital Expenditures $0.00 $0.00 $41.00K
Free Cash Flow -$850.0K -$1.000M -$1.461M
YoY Change -19.81% -31.55% 89.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Trading Symbol
TradingSymbol
MGT
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14042246 shares
CY2015Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1492000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
1492000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
309452000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
308288000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-300457000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-299163000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
8727000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
8855000 USD
CY2015Q1 us-gaap Minority Interest
MinorityInterest
355000 USD
CY2014Q4 us-gaap Minority Interest
MinorityInterest
442000 USD
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9082000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9297000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10574000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10676000 USD
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12853381 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10731160 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12853381 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10731160 shares
CY2014Q1 us-gaap Revenues
Revenues
85000 USD
CY2015Q1 us-gaap Revenues
Revenues
217000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
36000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1264000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1341000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1305000 USD
CY2014Q1 mgt Interest And Other Non Operating Income Expense
InterestAndOtherNonOperatingIncomeExpense
3000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1302000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1381000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-1292000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-1381000 USD
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-170000 USD
CY2015Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-87000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1122000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1294000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8796041 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11260174 shares
CY2014Q1 us-gaap Depreciation
Depreciation
11000 USD
CY2015Q1 us-gaap Depreciation
Depreciation
10000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
123000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
94000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
159000 USD
CY2014Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
9000 USD
CY2015Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1424000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-997000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-150000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1466000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1072000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3187000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-75000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4642000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1455000 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of estimates and assumptions and critical accounting estimates and assumptions &#160;</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.8pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.8pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.8pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company&#8217;s critical accounting estimates and assumptions affecting the financial statements were &#8220;Carrying Value of the Long-lived Assets&#8221;, &#8220;Valuation Allowance for Deferred Tax Assets&#8221; and &#8220;Valuation of Equity Instruments&#8221;.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.8pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.8pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; TEXT-INDENT: 37.8pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
9555 shares
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
10913 shares
CY2014Q1 mgt Warrants Antidilutive
WarrantsAntidilutive
920829 shares
CY2015Q1 mgt Warrants Antidilutive
WarrantsAntidilutive
1020825 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
96677 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
96000 shares
CY2014Q1 us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
142 shares
CY2015Q1 us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
150 shares
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-87000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
415000 shares
CY2015Q1 mgt Percentage Of Stockholder Incentive Stock Option Granted On Date Of Grant
PercentageOfStockholderIncentiveStockOptionGrantedOnDateOfGrant
0.1 pure
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
61000 USD
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
283000 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9M11D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9M7D
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
30000 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
19000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
49000 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
90000 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
0 USD
CY2015Q1 us-gaap Goodwill
Goodwill
6444000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
6444000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2000 USD
CY2015Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
773000 USD
CY2014Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
952000 USD
CY2014Q1 mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
42000 USD
CY2015Q1 mgt Sales Revenue Gaming Gross
SalesRevenueGamingGross
217000 USD
CY2014Q1 mgt Cost Of Services Gaming
CostOfServicesGaming
49000 USD
CY2015Q1 mgt Cost Of Services Gaming
CostOfServicesGaming
90000 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17000 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
79000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
103607 shares
CY2015Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
62000 USD
CY2015Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1129000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2267000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
132000 USD
CY2014 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
41000 USD
CY2014 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
790000 USD
CY2014 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2014Q1 us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
402000 USD
CY2015Q1 us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
179000 USD
CY2014Q1 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
2000 USD
CY2015Q1 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
101000 USD
CY2014Q1 mgt Proceeds From Issunace Of Common Stock Net Of Fees
ProceedsFromIssunaceOfCommonStockNetOfFees
1466000 USD
CY2015Q1 mgt Proceeds From Issunace Of Common Stock Net Of Fees
ProceedsFromIssunaceOfCommonStockNetOfFees
1072000 USD
CY2015Q1 mgt Sale Of Stock Offering Price
SaleOfStockOfferingPrice
8500000 USD
CY2015Q1 mgt Manager Fee Percentage On Gross Sales Price
ManagerFeePercentageOnGrossSalesPrice
0.030 pure
CY2015Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
1419000 USD
CY2015Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
5400000 USD
CY2015Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3155051 shares
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1695000 USD
CY2015Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
251000 USD
CY2014Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
43000 USD
CY2015Q1 us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
CY2014Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
CY2015Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
251000 USD
CY2014Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
123000 USD
CY2015Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
32000 USD
CY2015Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1020825 shares

Files In Submission

Name View Source Status
0001144204-15-031615-index-headers.html Edgar Link pending
0001144204-15-031615-index.html Edgar Link pending
0001144204-15-031615.txt Edgar Link pending
0001144204-15-031615-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mgt-20150331.xml Edgar Link completed
mgt-20150331.xsd Edgar Link pending
mgt-20150331_cal.xml Edgar Link unprocessable
mgt-20150331_def.xml Edgar Link unprocessable
mgt-20150331_lab.xml Edgar Link unprocessable
mgt-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v410072_10q.htm Edgar Link pending
v410072_ex31-1.htm Edgar Link pending
v410072_ex31-2.htm Edgar Link pending
v410072_ex32-1.htm Edgar Link pending
v410072_ex32-2.htm Edgar Link pending